48,706
edits
(→DDx: +note about esophagus) |
m (→Treatment) |
||
Line 15: | Line 15: | ||
===Treatment=== | ===Treatment=== | ||
*[[Imatinib]] (Gleevec) - drug was developed for [[chronic myelogenous leukemia]]. | *[[Imatinib]] (Gleevec) - drug was developed for [[chronic myelogenous leukemia]]. | ||
**There are other similar drugs, e.g. ''nilotinib'' and ''dasatinib''. | **There are other similar drugs, e.g. ''[[nilotinib]]'' and ''[[dasatinib]]''. | ||
===Factors predictive of malignant behaviour=== | ===Factors predictive of malignant behaviour=== |
edits